Edelweiss ARC sells Ind-Swift Laboratories shares worth Rs.32-Cr
Edelweiss India Special Situations Fund II has sold 3,209,400 equity shares (5.26% stake) at INR 100.25 per share of publicly listed Ind-Swift Laboratories on March 22, 2024 through a bulk deal on the NSE. The sale aggregates to INR 32.17 crore.
Want to receive such news items in your inbox? Click Here to sign up for a trial.